Tag archives


Publisher:  EHRA

“This case study looks at the challenges faced in sustaining HIV prevention programmes among KAPs, implemented primarily by civil society organisations (CSO’s), as a result of the withdrawal of the Global Fund through the transition period of 2020 to 2022 and the lack of government capacity and resources to maintain the already limited services that will likely result in the re-emergence of HIV epidemics among people who inject drugs (PWID), sex workers (SW) and men who have sex with men (MSM).”

This entry was posted in and tagged , , on by .

People with HIV, tuberculosis and malaria talk about their experiences and the connection between human rights and HIV work.

Our friends at Action Against AIDS conducted three interviews to discuss the connections between human rights and HIV work. The videos, embedded below, highlight the needs of people who are all too often marginalized and emphasize the need to focus on human rights principles. The interviewees share their concerns if we loose focus and start to chip away the gains we have made.

Maurine Murenga, a HIV-positive mother from Kenya, and GFAN Speaker , explains the importance of access to medicines for the treatment and prevention of HIV and malaria.

This entry was posted in Blog and tagged , on by .

Publisher: UNAIDS

“The struggle to end the AIDS epidemic continues to be inextricably linked with the struggle to end
human rights violations, including discrimination and violence against women and girls and the
marginalization and criminalization of key populations—sex workers, people who use drugs, gay men
and other men who have sex with men, transgender people and prisoners.

This report argues that power in fact rests in the hands of the people, as can be seen in countless local, national and international movements to redistribute power and bring greater attention to neglected issues.”

This entry was posted in and tagged on by .

Publisher:  World Health Organisation (WHO)

“The World Health Organization (WHO) has updated its guidance for the use of lateral flow urine lipoarabinomannan assay (LAM) in the diagnosis of tuberculosis (TB). Tests based on the detection of mycobacterial LAM antigen in urine have emerged as potential point-of-care tests for TB. The WHO Global TB Programme recommended the use of LF-LAM for the first time in 2015. Urinary LAM assays have shown greater sensitivity when used for the diagnosis of TB in people living with HIV. The sensitivity increases significantly in patients with lower CD4 cell counts. Following the new evidence, WHO is now recommending LF-LAM use to assist in diagnosis in a broader group of people, both in inpatient and outpatient settings.”

Source: Policy Update

This entry was posted in and tagged , on by .

Publisher: Frontline AIDS

The introduction of combination antiretroviral therapy (ART) in 1996 was one of the most significant interventions in the history of the HIV response. Combination therapy today means that in many parts of the world, AIDS is no longer seen as a death sentence. However, in the early days of the AIDS epidemic, very few people could access this treatment. People living with HIV led efforts across the world to improve access to treatment including campaigning to reduce the prices of HIV medicines. In 2018, over 23 million people were accessing ART but the struggle to ensure affordable access to treatment for all is not over.

This entry was posted in and tagged , on by .

Publisher: Friends of the Global Fight Against AIDS, Tuberculosis and Malaria

The world has made remarkable progress over the past two decades to address AIDS, tuberculosis and malaria, and increased investment can help ensure disease resurgence does not undo these gains. Stepped-up funding for the Global Fund and U.S. bilateral programs is our best defense against future disease resurgence.

The path forward is clear: to end AIDS, tuberculosis and malaria, we must scale up prevention and treatment, strengthen surveillance systems and invest in innovation. Drawing on historical examples and empirical evidence about resurgence, this new report demonstrates why it is crucial for U.S. policymakers to invest in the Global Fund.

This entry was posted in and tagged , , on by .